Genomically Informed Custom Selective Enrichment of Shiga Toxigenic Escherichia coli (STEC) Outbreak Strains in Foods Using Antibiotics.


Journal

Journal of food protection
ISSN: 1944-9097
Titre abrégé: J Food Prot
Pays: United States
ID NLM: 7703944

Informations de publication

Date de publication:
03 2023
Historique:
received: 27 10 2022
revised: 19 01 2023
accepted: 20 01 2023
entrez: 14 3 2023
pubmed: 15 3 2023
medline: 16 3 2023
Statut: ppublish

Résumé

Shiga toxigenic Escherichia coli (STEC) have been implicated in major foodborne outbreaks worldwide. The STEC family of pathogens is biochemically diverse, and current microbiological methods for detecting STEC are limited by the lack of a universal selective enrichment approach and prone to interference by high levels of background microbiota associated with certain types of foods. A novel approach has been developed for the recovery of foodborne illness outbreak strains during outbreak investigations based on the analysis of whole genome sequence data of implicated clinical isolates to determine antimicrobial resistance (AMR) genes. The presence of certain AMR genes in STEC has been correlated with the ability to grow in the presence of a specific antibiotic, which can be used to supplement enrichment broths to improve the recovery of a target strain. The enhanced recovery of STEC strains with different AMR profiles from various food types (beef, sprouts, leafy greens, and raw milk cheese) containing high levels of background microbiota was demonstrated using AMR predictions for nine different antibiotics. This genomically informed custom selective enrichment approach increases the availability of analytical options and improves the reliability of food microbiological analyses in confirming food vehicles implicated in outbreak events and defining the scope of product contamination to support risk assessment and risk management actions.

Identifiants

pubmed: 36916559
pii: S0362-028X(23)06721-2
doi: 10.1016/j.jfp.2023.100052
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100052

Informations de copyright

Crown Copyright © 2023. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kyle Tapp (K)

Ottawa Laboratory Carling, Canadian Food Inspection Agency, Ottawa, Ontario, Canada.

Mylène Deschênes (M)

Ottawa Laboratory Carling, Canadian Food Inspection Agency, Ottawa, Ontario, Canada.

Ashley Cooper (A)

Ottawa Laboratory Carling, Canadian Food Inspection Agency, Ottawa, Ontario, Canada.

Catherine Carrillo (C)

Ottawa Laboratory Carling, Canadian Food Inspection Agency, Ottawa, Ontario, Canada.

Burton Blais (B)

Ottawa Laboratory Carling, Canadian Food Inspection Agency, Ottawa, Ontario, Canada. Electronic address: Burton.Blais@inspection.gc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH